Michelle McIntyre
Nurse Practitioner · Hermiston, ORNPI 1013337211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 29.8% of the total. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$808
- Boehringer Ingelheim$236
- AstraZeneca$228
- Novo Nordisk$211
- GSK$178
- Otsuka America Pharmaceutical, Inc.$172
- plus $873 from 16 others
What the payments were for
- Food & beverage$2,707100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $808 |
| Boehringer Ingelheim | 10 | $236 |
| AstraZeneca | 10 | $228 |
| Novo Nordisk | 13 | $211 |
| GSK | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Sanofi Pasteur Inc. | 5 | $123 |
| Pfizer | 7 | $119 |
| Rhythm Pharmaceuticals, Inc. | 3 | $80 |
| Lilly USA, LLC | 4 | $79 |
| Bayer | 5 | $79 |
| Lundbeck LLC | 4 | $78 |
| Sanofi-aventis U.S. LLC | 3 | $61 |
| Novartis | 3 | $58 |
| Merck | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Baxter Healthcare | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,707 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 38 | $46,951 |
| FarxigaDapagliflozin Propanediol | 22 | $27,285 |
| OzempicSemaglutide | 19 | $26,364 |
| JardianceEmpagliflozin | 15 | $19,481 |
| EliquisApixaban | 24 | $17,897 |
| RexultiBrexpiprazole | 14 | $16,913 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $13,220 |
| Rosuvastatin Calcium | 39 | $2,513 |
| Potassium Citrate ErPotassium Citrate | 19 | $2,038 |
| Levothyroxine Sodium | 203 | $1,947 |
| Atorvastatin Calcium | 182 | $1,947 |
| Losartan Potassium | 154 | $1,777 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,393 |
| ValacyclovirValacyclovir Hcl | 17 | $1,080 |
| Lisinopril | 109 | $1,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $79 | $46,95138 claims |
| AstraZenecaFarxiga | $228 | $27,28522 claims |
| Novo NordiskOzempic | $211 | $26,36419 claims |
| Boehringer IngelheimJardiance | $236 | $19,48115 claims |
| PfizerEliquis | $119 | $17,89724 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $172 | $16,91314 claims |
| GSKTrelegy Ellipta | $178 | $13,22015 claims |
| AbbVieSynthroid | $808 | $70913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 997 nurse practitioner providers in Oregon.
Other nurse practitioner in Hermiston
- Randi NielsenHermiston$2K
- Alicia DuyvejonckSpringfield$299K
- Summer HarnessLake Oswego$113K
- Alana WilsonPortland$58K
- Jennifer MurdochPortland$15K
- Berhane MebratuPortland$10K
- Desiree CihelkaSpringfield$8K
- Amy CarterPortland$8K
- Margaret McLainCoos Bay$8K
- Mallory CrownoverSpringfield$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.